By entering this site you acknowledge that all products are provided for laboratory and research purposes only and are not for human or animal consumption.
You must be 21 years of age or older and a qualified research or business customer to proceed.
SLU-PP-332 has been studied in preclinical models involving estrogen-related receptor signaling, mitochondrial function, oxidative metabolism, skeletal-muscle energy pathways, fatty-acid oxidation and exercise-associated metabolic adaptations.
100mcg | 60 Capsules
For Research Use Only. Products sold by V1 Peptides are intended strictly for laboratory and research purposes. They are not for human or veterinary consumption, not drugs, and not intended to diagnose, treat, cure, or prevent any disease. Sold for licensed B2B and qualified research customers.
SLU-PP-332 is an experimental small-molecule compound developed for research involving the estrogen-related receptor (ERR) family of nuclear receptors.
It has attracted scientific interest as a synthetic ERR agonist and has been investigated in preclinical models examining how activation of these nuclear receptors influences mitochondrial biology, oxidative metabolism, cellular energy utilization and exercise-associated metabolic pathways.